| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Mar 14, 2024 | Option Exercise | $1.60 | 250,000 | 400,000 | 978,388 | Mar 15, 2024, 04:19 PM | |
| RGLS | Regulus Therapeutics Inc. | CALSADA CRISPINA | Chief Financial Officer | Jan 18, 2024 | Sale | $1.19 | 5,468 | 6,510 | 5,782 | Jan 18, 2024, 08:24 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Jan 18, 2024 | Sale | $1.19 | 5,468 | 6,510 | 10,056 | Jan 18, 2024, 08:23 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | Chief Executive Officer | Jan 18, 2024 | Sale | $1.19 | 14,580 | 17,359 | 57,112 | Jan 18, 2024, 08:22 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Apr 13, 2023 | Option Exercise | $0.90 | 222,198 | 200,000 | 728,388 | Apr 14, 2023, 04:39 PM | |
| RGLS | Regulus Therapeutics Inc. | Drygin Denis | Chief Scientific Officer | Mar 01, 2022 | Buy | $0.23 | 76,686 | 17,638 | 100,000 | Mar 01, 2022, 05:58 PM | |
| RGLS | Regulus Therapeutics Inc. | Drygin Denis | Chief Scientific Officer | Feb 04, 2022 | Buy | $0.23 | 23,314 | 5,362 | 23,314 | Feb 07, 2022, 05:09 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Jan 26, 2022 | Buy | $0.22 | 100,000 | 21,520 | 417,006 | Jan 26, 2022, 04:13 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Nov 30, 2021 | Option Exercise | $0.36 | 2,222,222 | 800,000 | 5,061,929 | Dec 01, 2021, 04:12 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | May 17, 2021 | Sale | $0.89 | 860 | 765 | 41,754 | May 17, 2021, 07:12 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Feb 16, 2021 | Sale | $1.72 | 4,144 | 7,128 | 244,628 | Apr 16, 2021, 04:11 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Feb 16, 2021 | Sale | $1.72 | 828 | 1,424 | 42,614 | Feb 17, 2021, 05:23 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Feb 16, 2021 | Sale | $1.72 | 4,144 | 7,128 | 485,756 | Feb 17, 2021, 05:23 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 04, 2020 | Option Exercise | $0.63 | 793,528 | 500,002 | 2,839,707 | Jan 27, 2021, 08:16 PM | |
| RGLS | Regulus Therapeutics Inc. | Walker Paul Edward | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:14 PM | |
| RGLS | Regulus Therapeutics Inc. | Sonsini Peter W. | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:13 PM | |
| RGLS | Regulus Therapeutics Inc. | SANDELL SCOTT D | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:12 PM | |
| RGLS | Regulus Therapeutics Inc. | MAKOWER JOSHUA | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:12 PM | |
| RGLS | Regulus Therapeutics Inc. | Makhzoumi Mohamad | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:11 PM | |
| RGLS | Regulus Therapeutics Inc. | Florence Anthony A. Jr. | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:10 PM | |
| RGLS | Regulus Therapeutics Inc. | Chang Carmen | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:10 PM | |
| RGLS | Regulus Therapeutics Inc. | Behbahani Ali | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:09 PM | |
| RGLS | Regulus Therapeutics Inc. | BASKETT FOREST | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:08 PM | |
| RGLS | Regulus Therapeutics Inc. | NEA 16 GP, LLC | 10% Owner | Dec 04, 2020 | Buy | $0.62 | 4,398,602 | 2,735,930 | 6,451,056 | Dec 07, 2020, 05:06 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Dec 04, 2020 | Option Exercise | $0.63 | 39,680 | 25,002 | 225,674 | Dec 07, 2020, 04:22 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 04, 2020 | Option Exercise | $0.63 | 793,528 | 500,002 | 1,986,729 | Dec 07, 2020, 04:21 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Nov 16, 2020 | Sale | $0.52 | 876 | 456 | 25,762 | Nov 18, 2020, 04:10 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Nov 16, 2020 | Sale | $0.52 | 6,094 | 3,176 | 215,994 | Nov 18, 2020, 04:09 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Aug 14, 2020 | Sale | $0.60 | 4,245 | 2,568 | 222,088 | Aug 17, 2020, 08:22 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Aug 14, 2020 | Sale | $0.61 | 872 | 528 | 26,638 | Aug 17, 2020, 08:21 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | May 15, 2020 | Sale | $0.63 | 4,426 | 2,774 | 226,333 | May 18, 2020, 04:28 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | May 15, 2020 | Sale | $0.63 | 909 | 570 | 27,510 | May 18, 2020, 04:27 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Feb 18, 2020 | Sale | $0.83 | 4,324 | 3,591 | 230,759 | Feb 19, 2020, 06:09 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Feb 18, 2020 | Sale | $0.83 | 888 | 737 | 28,419 | Feb 19, 2020, 06:08 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Jan 02, 2020 | Sale | $0.97 | 8,345 | 8,067 | 235,083 | Jan 03, 2020, 04:07 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Jan 02, 2020 | Sale | $0.97 | 2,239 | 2,164 | 29,307 | Jan 03, 2020, 04:06 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Nov 14, 2019 | Sale | $0.64 | 833 | 533 | 31,546 | Nov 15, 2019, 05:37 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Nov 14, 2019 | Sale | $0.64 | 5,838 | 3,736 | 243,428 | Nov 15, 2019, 05:36 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Oct 01, 2019 | Sale | $0.68 | 2,346 | 1,602 | 32,379 | Oct 02, 2019, 06:50 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Oct 01, 2019 | Sale | $0.68 | 8,743 | 5,969 | 249,266 | Oct 02, 2019, 06:17 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Aug 15, 2019 | Sale | $0.55 | 4,375 | 2,409 | 258,009 | Aug 16, 2019, 04:17 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Aug 15, 2019 | Sale | $0.55 | 899 | 495 | 34,725 | Aug 16, 2019, 04:16 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Jul 01, 2019 | Sale | $1.31 | 5,783 | 7,584 | 262,384 | Jul 02, 2019, 05:42 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Jul 01, 2019 | Sale | $1.31 | 2,225 | 2,918 | 35,624 | Jul 02, 2019, 05:42 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Jul 01, 2019 | Sale | $1.31 | 2,669 | 3,500 | 77,870 | Jul 02, 2019, 05:41 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | May 07, 2019 | Option Exercise | $1.08 | 370,370 | 400,000 | 1,189,872 | May 21, 2019, 04:46 PM | |
| RGLS | Regulus Therapeutics Inc. | RASTETTER WILLIAM H | Director | May 07, 2019 | Option Exercise | $1.08 | 92,889 | 100,320 | 154,223 | May 21, 2019, 04:45 PM | |
| RGLS | Regulus Therapeutics Inc. | Witz Pascale | Director | May 07, 2019 | Option Exercise | $1.08 | 29,630 | 32,000 | 37,849 | May 21, 2019, 04:44 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | May 07, 2019 | Option Exercise | $1.08 | 33,194 | 35,850 | 64,542 | May 21, 2019, 04:42 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | May 16, 2019 | Sale | $1.22 | 39,352 | 47,966 | 268,167 | May 16, 2019, 05:25 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | May 15, 2019 | Sale | $1.41 | 10,000 | 14,089 | 80,539 | May 16, 2019, 05:21 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | May 15, 2019 | Sale | $1.41 | 6,950 | 9,796 | 59,309 | May 16, 2019, 05:21 PM | |
| RGLS | Regulus Therapeutics Inc. | Walker Paul Edward | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 10, 2019, 10:59 AM | |
| RGLS | Regulus Therapeutics Inc. | Walker Paul Edward | Director | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:08 PM | |
| RGLS | Regulus Therapeutics Inc. | Sonsini Peter W. | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:07 PM | |
| RGLS | Regulus Therapeutics Inc. | SANDELL SCOTT D | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:07 PM | |
| RGLS | Regulus Therapeutics Inc. | MOTT DAVID M | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:06 PM | |
| RGLS | Regulus Therapeutics Inc. | MAKOWER JOSHUA | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:06 PM | |
| RGLS | Regulus Therapeutics Inc. | Makhzoumi Mohamad | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:05 PM | |
| RGLS | Regulus Therapeutics Inc. | Florence Anthony A. Jr. | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:05 PM | |
| RGLS | Regulus Therapeutics Inc. | Chang Carmen | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:05 PM | |
| RGLS | Regulus Therapeutics Inc. | Behbahani Ali | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:04 PM | |
| RGLS | Regulus Therapeutics Inc. | BASKETT FOREST | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:04 PM | |
| RGLS | Regulus Therapeutics Inc. | BARRIS PETER J | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:02 PM | |
| RGLS | Regulus Therapeutics Inc. | NEA Partners 16, L.P. | 10% Owner | May 07, 2019 | Buy | $1.08 | 1,136,704 | 1,227,640 | 2,052,454 | May 09, 2019, 06:02 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | May 07, 2019 | Buy | $1.08 | 33,194 | 35,850 | 64,542 | May 08, 2019, 05:15 PM | |
| RGLS | Regulus Therapeutics Inc. | Witz Pascale | Director | May 07, 2019 | Buy | $1.08 | 29,630 | 32,000 | 37,849 | May 08, 2019, 05:15 PM | |
| RGLS | Regulus Therapeutics Inc. | RASTETTER WILLIAM H | Director | May 07, 2019 | Buy | $1.08 | 92,889 | 100,320 | 154,223 | May 08, 2019, 05:14 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | May 07, 2019 | Buy | $1.08 | 370,370 | 400,000 | 1,189,872 | May 08, 2019, 05:13 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Apr 01, 2019 | Sale | $0.98 | 5,842 | 5,731 | 31,348 | Apr 03, 2019, 04:31 PM | |
| RGLS | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Apr 01, 2019 | Sale | $0.98 | 2,710 | 2,659 | 6,287 | Apr 03, 2019, 04:15 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Apr 01, 2019 | Sale | $0.98 | 3,253 | 3,192 | 9,372 | Apr 03, 2019, 12:00 AM | |
| RGLS | Regulus Therapeutics Inc. | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Feb 05, 2019 | Option Exercise | $0.95 | 40,000 | 38,000 | 62,893 | Feb 06, 2019, 04:52 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Feb 05, 2019 | Option Exercise | $0.95 | 65,000 | 61,750 | 84,148 | Feb 06, 2019, 04:51 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Feb 05, 2019 | Option Exercise | $0.95 | 30,000 | 28,500 | 34,578 | Feb 06, 2019, 04:50 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 28, 2018 | Buy | $1.09 | 50,000 | 54,570 | 835,073 | Jan 02, 2019, 04:12 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 26, 2018 | Buy | $0.95 | 90,000 | 85,878 | 758,672 | Dec 28, 2018, 04:21 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 27, 2018 | Buy | $1.04 | 26,401 | 27,460 | 785,073 | Dec 28, 2018, 04:21 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Nov 15, 2018 | Buy | $1.33 | 200,000 | 265,080 | 368,672 | Nov 19, 2018, 04:03 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Nov 16, 2018 | Buy | $1.38 | 300,000 | 415,470 | 668,672 | Nov 19, 2018, 04:03 PM | |
| RGLS | Regulus Therapeutics Inc. | Collier Kathryn J | Director | Nov 16, 2018 | Buy | $1.41 | 7,100 | 10,011 | 27,596 | Nov 19, 2018, 04:01 PM | |
| RGLS | Regulus Therapeutics Inc. | Collier Kathryn J | Director | Jun 05, 2018 | Option Exercise | $0.74 | 7,695 | 5,694 | 7,695 | Jun 05, 2018, 04:28 PM | |
| RGLS | Regulus Therapeutics Inc. | Collier Kathryn J | Director | Apr 14, 2018 | Option Exercise | $0.64 | 60,234 | 38,550 | 60,234 | Apr 17, 2018, 04:36 PM | |
| RGLS | Regulus Therapeutics Inc. | BALTIMORE DAVID | Director | Dec 04, 2017 | Option Exercise | $0.89 | 60,674 | 54,000 | 60,674 | Dec 06, 2017, 07:43 PM | |
| RGLS | Regulus Therapeutics Inc. | FOLETTA MARK G | Director | Dec 04, 2017 | Option Exercise | $0.89 | 71,910 | 64,000 | 81,910 | Dec 06, 2017, 07:42 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Dec 04, 2017 | Option Exercise | $0.89 | 96,629 | 86,000 | 1,797,306 | Dec 06, 2017, 07:41 PM | |
| RGLS | Regulus Therapeutics Inc. | Rosen Hugh | Director | Dec 04, 2017 | Option Exercise | $0.89 | 56,179 | 49,999 | 56,179 | Dec 06, 2017, 07:40 PM | |
| RGLS | Regulus Therapeutics Inc. | Witz Pascale | Director | Dec 04, 2017 | Option Exercise | $0.89 | 60,674 | 54,000 | 60,674 | Dec 06, 2017, 07:39 PM | |
| RGLS | Regulus Therapeutics Inc. | RASTETTER WILLIAM H | Director | Dec 04, 2017 | Option Exercise | $0.89 | 69,662 | 61,999 | 694,387 | Dec 06, 2017, 07:38 PM | |
| RGLS | Regulus Therapeutics Inc. | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Jul 25, 2017 | Buy | $0.91 | 274,725 | 250,000 | 274,725 | Jul 25, 2017, 06:09 PM | |
| RGLS | Regulus Therapeutics Inc. | RASTETTER WILLIAM H | Director | Jul 25, 2017 | Buy | $0.91 | 274,725 | 250,000 | 624,625 | Jul 25, 2017, 06:09 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Jul 25, 2017 | Buy | $0.91 | 219,780 | 200,000 | 241,297 | Jul 25, 2017, 06:08 PM | |
| RGLS | Regulus Therapeutics Inc. | Chevallard Daniel R. | Chief Financial Officer | Jul 25, 2017 | Buy | $0.91 | 54,945 | 50,000 | 59,415 | Jul 25, 2017, 06:07 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Jul 25, 2017 | Buy | $0.91 | 1,000,000 | 910,000 | 1,770,677 | Jul 25, 2017, 06:06 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Mar 21, 2017 | Buy | $1.20 | 200,000 | 239,800 | 400,677 | Mar 23, 2017, 04:26 PM | |
| RGLS | Regulus Therapeutics Inc. | PAPADOPOULOS STELIOS | Director | Mar 22, 2017 | Buy | $1.23 | 300,000 | 368,100 | 700,677 | Mar 23, 2017, 04:26 PM | |
| RGLS | Regulus Therapeutics Inc. | RASTETTER WILLIAM H | Director | Mar 07, 2017 | Buy | $1.15 | 250,000 | 287,500 | 350,000 | Mar 07, 2017, 04:59 PM | |
| RGLS | Regulus Therapeutics Inc. | Hagan Joseph P | Chief Operating Officer | Mar 03, 2016 | Buy | $7.19 | 10,000 | 71,900 | 10,000 | Mar 07, 2016, 05:20 PM | |
| RGLS | Regulus Therapeutics Inc. | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Feb 23, 2016 | Sale | $7.18 | 1,000,000 | 7,180,000 | 4,896,716 | Feb 24, 2016, 06:20 PM | |
| RGLS | Regulus Therapeutics Inc. | FOLETTA MARK G | Director | Aug 13, 2015 | Buy | $7.64 | 10,000 | 76,405 | 10,000 | Aug 13, 2015, 06:10 PM |
Menu